CACTUS GRANDIFLORUS (HOMEOLAB USA INC.)


Welcome to the PulseAid listing for the CACTUS GRANDIFLORUS drug offered from HOMEOLAB USA INC.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: HOMEOLAB USA INC.
NON-PROPRIETARY NAME: CACTUS GRANDIFLORUS
SUBSTANCE NAME: SELENICEREUS GRANDIFLORUS STEM
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: PELLET
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 1995-10-11
END MARKETING DATE: 0000-00-00


CACTUS GRANDIFLORUS HUMAN OTC DRUG Details:

Item DescriptionCACTUS GRANDIFLORUS from HOMEOLAB USA INC.
LABELER NAME: HOMEOLAB USA INC.
DEA SCHEDULE:
ACTIVE STRENGTH: 3([hp_X]/1)
START MARKETING DATE: 1995-10-11
END MARKETING DATE: 0000-00-00
PRODUCT ID: 60512-6558_e64e2a8f-f797-4149-8b82-ca11e3c83650
PRODUCT NDC: 60512-6558
APPLICATION NUMBER:

Other SELENICEREUS GRANDIFLORUS STEM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
HOMEOLAB USA INC.CACTUS GRANDIFLORUS
Natural Health SupplyNHS Spasms Weakness
Paramesh Banerji Life Sciences LLCCactus grandiflorus 200C
Rxhomeo Private Limited d.b.a. Rxhomeo, IncCACTUS GRANDIFLORUS
Seroyal USACACTUS GRANDIFLORUS
Washington Homeopathic ProductsCactus grandiflorus